Quasi-experimental, Nonrandomized Initiative to Minimize Sleep Disruptions among Hospitalized Children
- PMID: 37434593
- PMCID: PMC10332835
- DOI: 10.1097/pq9.0000000000000666
Quasi-experimental, Nonrandomized Initiative to Minimize Sleep Disruptions among Hospitalized Children
Abstract
Hospitalized children experience frequent sleep disruptions. We aimed to reduce caregiver-reported sleep disruptions of children hospitalized on the pediatric hospital medicine service by 10% over 12 months.
Methods: In family surveys, caregivers cited overnight vital signs (VS) as a primary contributor to sleep disruption. We created a new VS frequency order of "every 4 hours (unless asleep between 2300 and 0500)" as well as a patient list column in the electronic health record indicating patients with this active VS order. The outcome measure was caregiver-reported sleep disruptions. The process measure was adherence to the new VS frequency. The balancing measure was rapid responses called on patients with the new VS frequency.
Results: Physician teams ordered the new VS frequency for 11% (1,633/14,772) of patient nights on the pediatric hospital medicine service. Recorded VS between 2300 and 0500 was 89% (1,447/1,633) of patient nights with the new frequency ordered compared to 91% (11,895/13,139) of patient nights without the new frequency ordered (P = 0.01). By contrast, recorded blood pressure between 2300 and 0500 was only 36% (588/1,633) of patient nights with the new frequency but 87% (11,478/13,139) of patient nights without the new frequency (P < 0.001). Overall, caregivers reported sleep disruptions on 24% (99/419) of reported nights preintervention, which decreased to 8% (195/2,313) postintervention (P < 0.001). Importantly, there were no adverse safety issues related to this initiative.
Conclusion: This study safely implemented a new VS frequency with reduced overnight blood pressure readings and caregiver-reported sleep disruptions.
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Dr. Evan Orenstein is a co-founder and holds equity in Phrase Health©, a clinical decision support analytics company. He receives no direct revenue and is the principal investigator on an R42 grant with Phrase Health funded by the National Library of Medicine (NLM) and the National Center for Advancing Translational Sciences (NCATS). He receives salary support from NLM and NCATS. The other authors have no financial interest to declare.
Figures
References
-
- Irwin M, McClintick J, Costlow C, et al. . Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996;10:643–653. - PubMed
-
- Moldofsky H. Sleep and the immune system. Int J Immunopharmacol. 1995;17:649–654. - PubMed
-
- Meltzer LJ, Davis KF, Mindell JA. Patient and parent sleep in a children’s hospital. Pediatr Nurs. 2012;38:64–71. - PubMed
LinkOut - more resources
Full Text Sources